Scribe Therapeutics Inc. (SCTX)
NASDAQ: SCTX · Real-Time Price · USD
21.19
+0.46 (2.22%)
At close: Aug 17, 2026, 4:00 PM EDT
20.93
-0.26 (-1.23%)
After-hours: Aug 17, 2026, 5:10 PM EDT
Scribe Therapeutics Employees
Scribe Therapeutics had 89 employees as of March 31, 2026. The number of employees did not change since the number was last reported on December 31, 2025.
Employees
89
Change
n/a
Growth
n/a
Revenue / Employee
$407,663
Profits / Employee
-$401,461
Market Cap
399.74M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 89 | 0 | - |
| Dec 31, 2025 | 89 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Capricor Therapeutics | 231 |
| ProKidney | 231 |
| Rocket Pharmaceuticals | 202 |
| Enanta Pharmaceuticals | 120 |
| Upstream Bio | 75 |
| Lexeo Therapeutics | 63 |
| Atea Pharmaceuticals | 55 |
| Compass Therapeutics | 39 |
SCTX News
- 21 days ago - Scribe Therapeutics Announces Closing of Initial Public Offering, Full Exercise of Underwriters' Option to Purchase Additional Shares, and Closing of the Concurrent Private Placement - GlobeNewsWire
- 21 days ago - Opening Day: Scribe Therapeutics makes strong trading debut - TheFly
- 24 days ago - Scribe Therapeutics opens at $25, IPO priced at $15 per share - TheFly
- 24 days ago - Scribe Therapeutics indicated to open at $25, IPO priced at $15 per share - TheFly
- 24 days ago - Scribe Therapeutics indicated to open at $29.20, IPO priced at $15 per share - TheFly
- 24 days ago - Scribe Therapeutics 8.58M share IPO priced at $15.00 - TheFly
- 24 days ago - Scribe Therapeutics Announces Pricing of Upsized Initial Public Offering - GlobeNewsWire
- 6 weeks ago - Scribe Therapeutics IPO Registration Document (S-1) - SEC